Thousand Oaks, CA, United States of America

Justin Malinowski

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin Malinowski. Retrieved from https://idiyas.com/inventor/justin-malinowski-ffekypon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Justin Malinowski: Innovator in Pharmaceutical Chemistry

Introduction

Justin Malinowski is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzimidazole derivatives.

Latest Patents

Justin holds a patent for "Benzimidazole derivatives and their uses." This invention provides compounds that inhibit the activity of TRPC6, along with pharmaceutically acceptable salts, pharmaceutical compositions, methods for manufacturing these compounds, and their therapeutic uses. His work is crucial in advancing medical treatments and therapies.

Career Highlights

Justin is currently employed at Teijin Pharma Limited, where he continues to develop and refine his innovative ideas. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Justin has collaborated with talented individuals such as Angel Guzman-Perez and Brett Michael Johnson. These partnerships have fostered a creative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Justin Malinowski's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…